BergaCare SmartLipids: commercial lipophilic active concentrates for improved performance of dermal products

Florence Olechowski, Rainer H. Müller and Sung Min Pyo
Beilstein J. Nanotechnol. 2019, 10, 2152–2162. https://doi.org/10.3762/bjnano.10.208

Cite the Following Article

BergaCare SmartLipids: commercial lipophilic active concentrates for improved performance of dermal products
Florence Olechowski, Rainer H. Müller and Sung Min Pyo
Beilstein J. Nanotechnol. 2019, 10, 2152–2162. https://doi.org/10.3762/bjnano.10.208

How to Cite

Olechowski, F.; Müller, R. H.; Pyo, S. M. Beilstein J. Nanotechnol. 2019, 10, 2152–2162. doi:10.3762/bjnano.10.208

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 948.3 KB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Sharma, B.; Chauhan, I.; Kumar, G.; Tiwari, R. K. SmartLipids: Ushering in a New Era of Lipid Nanoparticles for Drug Delivery. Micro and Nanosystems 2024, 16, 88–96. doi:10.2174/0118764029294004240318094405
  • Yuan, Z.; Yan, R.; Fu, Z.; Wu, T.; Ren, C. Impact of physicochemical properties on biological effects of lipid nanoparticles: Are they completely safe. The Science of the total environment 2024, 927, 172240. doi:10.1016/j.scitotenv.2024.172240
  • Khafagy, E.-S.; Motawee, A. O.; Ghorab, M. M.; Gardouh, A. R. Atorvastatin-loaded pro-nanolipospheres with ameliorated oral bioavailability and antidyslipidemic activity. Colloids and surfaces. B, Biointerfaces 2023, 227, 113361. doi:10.1016/j.colsurfb.2023.113361
  • Neto, A. H. P.; Leite, L. L.; De Rossi, S. D.; Bonamigo, R. R. Air Pollution and the Skin Health. Dermatology in Public Health Environments; Springer International Publishing, 2023; pp 899–925. doi:10.1007/978-3-031-13505-7_37
  • Khan, S.; Sharma, A.; Jain, V. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Advanced pharmaceutical bulletin 2022, 13, 446–460. doi:10.34172/apb.2023.056
  • Wiemann, S.; Keck, C. M. Are lipid nanoparticles really superior? A holistic proof of concept study. Drug delivery and translational research 2021, 12, 1–12. doi:10.1007/s13346-021-01021-5
  • Keck, C. M.; Specht, D.; Brüßler, J. Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles. Journal of controlled release : official journal of the Controlled Release Society 2021, 338, 149–163. doi:10.1016/j.jconrel.2021.08.016
  • Sguizzato, M.; Esposito, E.; Cortesi, R. Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier. International journal of molecular sciences 2021, 22, 8319. doi:10.3390/ijms22158319
  • Vinceković, M.; Jurić, S.; Marijan, M.; Viskić, M.; Vlahoviček-Kahlina, K.; Bandić, L. M. Encapsulation of herb extracts (Aromatic and medicinal herbs). Aromatic Herbs in Food; Elsevier, 2021; pp 263–322. doi:10.1016/b978-0-12-822716-9.00008-1
  • Juszkiewicz, K.; Sikorski, A. F.; Czogalla, A. Building Blocks to Design Liposomal Delivery Systems. International journal of molecular sciences 2020, 21, 9559. doi:10.3390/ijms21249559

Patents

  • FOURNIAL ARNAUD; PLATCHECK RAFFIN RENATA; ROSSINI KOPP CRISTIELI. METHOD FOR ENCAPSULATING A HYDROPHOBIC COMPOUND, SUSPENSION OF STRUCTURED LIPID PARTICLES ACCORDING TO THIS METHOD, AND USES OF SAID SUSPENSION. WO 2023169963 A1, Sept 14, 2023.
  • FOURNIAL ARNAUD; PLATCHECK RAFFIN RENATA; ROSSINI KOPP CRISTIELI. Procédé d’encapsulation d’un composé hydrophobe, suspension de particules lipidiques structurées selon ce procédé et utilisations de ladite suspension. FR 3133126 A1, Sept 8, 2023.
Other Beilstein-Institut Open Science Activities